000			01521 a2200469 4500
005			20250515201559.0
264		0	_c20100707
008			201007s 0 0 eng d
022			_a1878-0210
024	7		_a10.1016/j.pcd.2009.11.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aNatarajan, B
245	0	0	_aClinical experience with exenatide in a routine secondary care diabetes clinic. _h[electronic resource]
260			_bPrimary care diabetes _cApr 2010
300			_a57-60 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aBlood Glucose _xdrug effects
650	0	4	_aBody Mass Index
650	0	4	_aBody Weight
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDrug Therapy, Combination
650	0	4	_aExenatide
650	0	4	_aGlycated Hemoglobin _xmetabolism
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aInsulin _xtherapeutic use
650	0	4	_aPeptides _xtherapeutic use
650	0	4	_aSulfonylurea Compounds _xtherapeutic use
650	0	4	_aTreatment Outcome
650	0	4	_aVenoms _xtherapeutic use
650	0	4	_aWeight Loss
700	1		_aEdavalath, M
700	1		_aDavies, J
700	1		_aJenkins, L
700	1		_aMarshall-Richards, N
700	1		_aEvans, D
700	1		_aPrice, D E
700	1		_aBain, S C
700	1		_aStephens, J W
773	0		_tPrimary care diabetes _gvol. 4 _gno. 1 _gp. 57-60
856	4	0	_uhttps://doi.org/10.1016/j.pcd.2009.11.001 _zAvailable from publisher's website
999			_c19403249 _d19403249